DE60106293D1 - Verfahren zur inhibierung von katarakten - Google Patents

Verfahren zur inhibierung von katarakten

Info

Publication number
DE60106293D1
DE60106293D1 DE60106293T DE60106293T DE60106293D1 DE 60106293 D1 DE60106293 D1 DE 60106293D1 DE 60106293 T DE60106293 T DE 60106293T DE 60106293 T DE60106293 T DE 60106293T DE 60106293 D1 DE60106293 D1 DE 60106293D1
Authority
DE
Germany
Prior art keywords
group
cataracts
inhibiting
inhibiting cataracts
benzoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60106293T
Other languages
English (en)
Other versions
DE60106293T2 (de
Inventor
Wang Anderson
Andreas Sashegyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE60106293D1 publication Critical patent/DE60106293D1/de
Publication of DE60106293T2 publication Critical patent/DE60106293T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60106293T 2000-10-25 2001-10-12 Verfahren zur inhibierung von katarakten Expired - Fee Related DE60106293T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24310100P 2000-10-25 2000-10-25
US243101P 2000-10-25
US25380000P 2000-11-29 2000-11-29
US253800P 2000-11-29
PCT/US2001/027766 WO2002034266A1 (en) 2000-10-25 2001-10-12 Method for inhibiting cataracts

Publications (2)

Publication Number Publication Date
DE60106293D1 true DE60106293D1 (de) 2004-11-11
DE60106293T2 DE60106293T2 (de) 2005-11-17

Family

ID=26935594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60106293T Expired - Fee Related DE60106293T2 (de) 2000-10-25 2001-10-12 Verfahren zur inhibierung von katarakten

Country Status (7)

Country Link
US (1) US20040087572A1 (de)
EP (1) EP1335727B1 (de)
AT (1) ATE278403T1 (de)
AU (1) AU2001296240A1 (de)
DE (1) DE60106293T2 (de)
ES (1) ES2228958T3 (de)
WO (1) WO2002034266A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100112881A1 (en) * 2008-11-03 2010-05-06 Pradip Bahukudumbi Composite material and method for manufacturing composite material
WO2015122954A2 (en) * 2013-11-27 2015-08-20 Humanetics Corporation Protecting tissue and mitigating injury from chemical exposure
JP7100019B2 (ja) 2016-08-19 2022-07-12 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 選択的エストロゲン受容体モジュレーター（ｓｅｒｍ）は、光受容体の変性に対する保護を付与する

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451589A (en) * 1993-12-21 1995-09-19 Eli Lilly And Company Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol

Also Published As

Publication number Publication date
EP1335727A1 (de) 2003-08-20
EP1335727B1 (de) 2004-10-06
WO2002034266A8 (en) 2003-11-06
WO2002034266A1 (en) 2002-05-02
US20040087572A1 (en) 2004-05-06
AU2001296240A1 (en) 2002-05-06
DE60106293T2 (de) 2005-11-17
WO2002034266A9 (en) 2002-08-15
ATE278403T1 (de) 2004-10-15
ES2228958T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
AP1541A (en) New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors.
BR0111596A (pt) Composto e seu uso, processo para sua produção, composição farmacêutica e processo e método para prevenir ou tratar doenças
ATE211147T1 (de) Tripeptidisches antithrombotisches mittel
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
DK0738262T3 (da) Hidtil ukendte heterocykliske forbindelser
BR0315417A (pt) Derivados 1-acil-pirrolidina para o tratamento de infecções virais
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
NO944927L (no) Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom
RU2011105813A (ru) Азотсодержащие гетероциклические соединения
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
ATE468109T1 (de) Liposomale abgabe von verbindungen auf vitamin-e- basis
MX9707531A (es) Nuevos compuestos heterociclicos.
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
DE602004020730D1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
EA200100090A3 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
DE60106293D1 (de) Verfahren zur inhibierung von katarakten
HUP0303020A2 (hu) Androgén 7-szubsztituált 11-halogénezett szteroidok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
ATE308513T1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente
ATE365162T1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
DK1276722T3 (da) Naphthamidin-urokinaseinhibitorer
HUP0102506A2 (hu) Benzotiofénszármazékok alkalmazása az acetil-kolin szint növelésére
EA200501083A1 (ru) Соединения, активные в ингибировании пролилолигопептидазы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee